ExploreWatchlistsPricing
  1. JP-listed companies
  2. OLYMPUS CORPORATION
  3. Financials
  4. Diluted EPS

OLYMPUS CORPORATION (7733)

Market cap
¥2.07T
P/E ratio
21.5x
Olympus manufactures medical endoscopes and therapeutic devices for hospitals and healthcare providers worldwide, specializing in gastrointestinal, surgical, and diagnostic equipment.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndDiluted EPS (JPY)YoY (%)
Mar 31, 202661.2-40.47%
Mar 31, 2025102.8-48.46%
Mar 31, 2024199.4+76.37%
Mar 31, 2023113.1+25.41%
Mar 31, 202290.2+798.11%
Mar 31, 202110-74.49%
Mar 31, 202039.4+560.40%
Mar 31, 20196-95.58%
Mar 31, 2018135-40.90%
Mar 31, 2017228.4+24.91%
Mar 31, 2016182.8+83.15%
Mar 31, 201599.8+143.25%
Mar 31, 201441

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat